cell-free-dna
(4)
Egor Melnikov Bet a Founder’s Life on a Family Idea
An economist from a Russian science town turned his father’s unfinished research into a decade-long biotech company. The useful lesson is not romance. It is his stubborn method: narrow the question, protect the idea, and keep earning the next experiment.
Diana Abdueva Is Teaching Blood to Keep Better Notes
The computational biologist behind Aqtual has spent two decades learning how to pull useful signals from noisy biology. Now she is building a company around a deceptively simple idea: the blood carries a running record of what the body is doing.
David Ge Builds the Quiet Machinery Behind Liquid Biopsy
Before a genomic test can read a signal, someone has to rescue it from the noise. David Ge has spent his career moving upstream - from interpreting DNA data to engineering the chemistry that decides what reaches the sequencer.
Shidong Jia
Shidong Jia, MD, PhD, is the founder and global CEO of Predicine, a Silicon Valley precision-oncology company building multi-omic liquid biopsy tests that read cancer from blood and urine. Trained as a physician-scientist at Harbin Medical University, Peking Union Medical College, Dana-Farber and Harvard, he ran oncology biomarker strategy at Genentech before leaving to start Predicine in 2015. His pitch is simple: precision diagnostics to enable precision medicine, built 'From Pharma, For Pharma.'